Stereotactic Surgery Devices Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 Market scenario

The global stereotactic surgery devices market size is expected to grow at a decent pace in the forthcoming years as per the market study released by Market Research Future (MRFR). The global market valuation stayed at USD 27.23 billion in 2030 and is projected to grow with a CAGR of 4.6% during the forecast period 2022-2030.

Stereotactic surgery is a surgical intervention method that is minimally invasive in nature and uses a 3D coordinate system for locating small targets comprising inside the body and performs various key actions like biopsy and ablation. This form of surgery is used for the treatment and diagnosis of various neurological conditions. In a stereotactic brain tumor surgery, the tumor is removed with the help of image guidance which is obtained previously.

The market is expected to showcase growth due to the increasing preference among the masses for minimally invasive form of surgeries and increasing prevalence of brain-related conditions like Parkinson’s disease. However, at the same time, the market growth can be constrained due to the high cost of installation and low charges of treatment which delays the recovery of the invested amount, one which thereby limits the adoption of the technology.

Competitive Landscape

The global stereotactic surgery devices market players includes, including GE Healthcare, Mitsubishi Heavy Industries, Ltd., Ferring B. V., Huiheng Medical, Inc., Varian Medical Systems, Koninklijke Philips N.V., Elekta AB, Accuray, Inc., Hitachi Medical Systems, and Shinva Medical Instrument Co., Ltd.

Market Segmentation

The market segmentation of the global stereotactic surgery devices is classified into the following key dynamics: product type and application.

By application, the market includes Parkinson’s disease, brain tumor, epilepsy, arteriovenous malformations, and others.

By product type, the market comprises of Linear accelerators (LINAC), gamma knife, proton beam therapy, and cyberknife. The Linear Accelerators segment is projected to hold the highest share of the market due to the growing rate of adoption and installations. In addition to these, the cyberknife segment is expected to be the fastest growing segment of mentioned product types over the assessment period due to its proliferating popularity and demand across developing economies.

Regional Analysis

The geographical segmentation of the global stereotactic surgery devices market insights covers the following key regions: the Americas, Asia Pacific, Europe, and the Middle East & Africa.

The Americas is the dominant region in the global landscape of stereotactic surgery devices. The region is expected to continue its global dominance in the forthcoming years as well. This is due to the increasing prevalence of neurological diseases, high disposable income, and the presence of an established healthcare infrastructure. The US contributes significantly to the overall Americas market, and its projected growth is expected to propel the entire regional market.

Europe holds the second largest position in the global stereotactic surgery devices market. The region is expected to hold on to its market position in the forthcoming years due to the growing occurrence of brain-related disease and presence of an established healthcare industry. The Asia Pacific region comprises of various leading and developing economies in the world, namely India, China, Australia, japan, Republic of Korea, and others. The region is expected to garner notable growth due to similar factors as that of the European region.

Finally, the Middle East & African regional market holds the least share in the global landscape and is expected to garner minimal growth percentage during the forecast period. The meagre growth of the region can be attributed to the Middle East region’s developed healthcare industry and growing number of initiatives undertaken by the government in favor of the healthcare sector. The growth in this region, particularly in the Middle East, is primarily spearheaded by countries like the United Arab Emirates (UAE) and Saudi Arabia.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Ticagrelor Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Market Overview

The global ticagrelor market size is predicted to grow USD 2.94 billion by 2030 a striking CAGR 6.40% during the forecast period 2023-2030 owing to the rising patient population suffering from heart problems, asserts Market Research Future (MRFR). Ticagrelor is referred to as an antiplatelet drug, a member of the pharmaceuticals sectionwhich helps to tackle the problem of platelet aggression. It keeps the platelets from coagulating in order to prevent unwanted blood clots that can occur with certain blood vessel or heartconditions. Ticagrelor outperformed an established product named Clopidogrel by the SOC in the clinical trials in terms of safety of the patients and end results. The drug is also used as an agent to reduce stent thrombosis. Ticagrelor is a product of an already established entity, AstraZeneca, and will be offered enough market space to achieve high growth rates in the market.

Competitive Dashboard

The global ticagrelor market players are

·        Alexion,

·        Ingelheim,

·        Roche,

·        Ingelheim Pfizer,

·        Pfizer,

·        GSK,

·        Boehringer,

·        Amgen,

·        Boehringer,

·        Merck,

·        Amgen, and

·        Eli Lilly.

Drivers and Constraints Impacting the Market

The global ticagrelor market is estimated to register a healthy CAGR due to several driving factors. With increasing patient population suffering from heart problems, the market is estimated to foster during the assessment period.Increasing product developmentby the companies, funding for research and development activities by the major market players, and improving market access scenarios are further estimated to propel the market. Moreover, owing to the presence of several well-established players, the ticagrelor market is estimated to flourish in the coming years.

On the flip side, side effects of ticagrelor such as chest pain, irregular heartbeat, shortness of breath, nose bleeding, and spots under the skin are some of the major concerns considered to impede the market growth during the estimated period.

Global Ticagrelor Market: Segmental Analysis

The global ticagrelor market has been segmented on the basis of end-users and region.

By mode of end-users, the global ticagrelor market has been segmented into hospitals, clinics, and medical institutions. Among these, the hospital segment is considered to experience a significant growth rate during the assessment period owing to the well-developed infrastructure and latest devices offered by the hospitals. Moreover, rising incidences of heart attacks are propelling the segment growth.

Regional Insights

Geographically, the ticagrelor market insights span across regions namely, Europe, Americas,Asia Pacific, and the Middle East & Africa.

Among all the regions, America occupies the largest market share of approx. more than 40% owing to the extensive use of the drug by the patients who are discharged from hospitals in this region. Moreover, presence of major manufactures in this region is further contributing to the market growth.

Europe is estimated to be the second largest market and is anticipated to maintain its dominance during the appraisal period owing to the increasing awareness of ticagrelor in this region. Moreover, well-developed hospital infrastructure has further promoted the market growth.

The Asia Pacific region is considered to expand at the fastest growth rate owing to the increased number of cardiovascular patients in this region. Economies such as China and India are predicted to be the fastest growing regions. Moreover, major key players are expanding their presence in this region which is further contributing to the market growth. For instance, Sun Pharmaceutical Industries Ltd.and AstraZeneca Pharma India Limited had announced that they had entered entered into a distribution services agreement in India for Axcer, which is a new brand of ticagrelor.

On the other hand, the Middle East & Africa is presumed to occupy the least market share owing to poor medical facilities, lack of awareness, and limited market scenario activities.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

CBD Hemp Oil Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 Market Insights

CBD Hemp oil has developed various medical applications such as pain relief, stress relief, treatment of anxiety and depression, diabetes prevention, heart health benefit, acne reduction, cancer symptom relief, and others. CBD hemp oil with approval is about to accelerate to utilize its medicinal properties. In addition, rising health spending worldwide is expected to spur the proliferation of the CBD hemp oil market size is projected to reach USD 5.1 billion by 2030 at a CAGR 17.20% during the forecasted year 2023-2030.

CBD hemp oil is also widely used to treat patients with neurological disorders. The growing group of patients with neurological disorders is also expected to contribute to the growth of the global market. In addition, delta-9-tetrahydrocannabinol, or THC present in oil as a major component, helps to improve immunity, which should stimulate market expansion.

The legalization of cannabis in various national markets is an essential factor in completing the growth of the global market. In addition, the innovations and developments introduced by key players in their product portfolios have revolutionized the market landscape by increasing sales. CBD Hemp oil is predicted to gain popularity in the coming years as a dietary supplement and body care product. This, in turn, should positively influence the CBD hemp oil market insights.

The market currently looks attractive and should grow in the coming years. Growth is due to the strong value of the growing health sector. Increased awareness of oil safety and efficiency is expected to increase the world market over the next two years.

Major Players

CBD hemp oil market players are NuLeaf Naturals, Canopy Growth Corporation, Medical Marijuana, Aphria Inc., Aurora Cannabis, CBD American Shaman, Elixinol, Folium Biosciences, PharmaHemp, Cannoid, and ENDOCA. New entrants with latest products that sync well with the global demand based on demographics is estimated to make the market more competitive for the well-established players.

Market Segmentation

The global CBD hemp oil market is broadly bifurcated based on distribution channel, product type, and application.

Based on the type, the global CBD hemp oil market is classified into spray, vape oil tincture, and others.

The distribution channel segment is also diversified into retail pharmacies, medical marijuana dispensaries, hospital pharmacies, and e-commerce websites.

Based on the application segment, the global CBD hemp oil market is divided into diabetes, mood disorders, pain relief, neurological disorder, and fibromyalgia.

Regional Insights

North America has a significant market share and is expected to grow in popularity in the coming years. Legalizing cannabis sales in Canada has projected the regional market on an upward path. A considerable increase in cannabis production is anticipated for the region, which is likely to upsurge the regional market over the next two years. The US market is also expected to expand considerably in the coming future. Factors supporting the development of the market in the region comprise widespread prevalence of chronic diseases, exponential aging of the population, adoption of oil to reduce neurological pain, etc.

At the same time, the Asia Pacific CBD hemp oil market is expected to grow remarkably soon. Significant growth in domestic markets such as China, India, and Japan are set to spur market expansion in the region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Kidney Biopsy Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Global Kidney Biopsy Market- Overview

Accrediting the kind of growth the market is witnessing and the growth prospect the market is demonstrating, Market Research Future (MRFR), has recently published a brilliant study report. According to MRFR, the Global Kidney Biopsy market size is expected to perceive exponential growth USD 3.31 billion by 2032, registering ~ 5.20% CAGR during the forecasted period 2023-2032.

The global market for Kidney biopsy or renal biopsy is growing pervasively over last decade. Factors such as increasing prevalence for kidney diseases & transplants are fuelling the market growth to an extent. Also the risk factors of kidney diseases & disorders like chronic high blood pressure & diabetes that are creating the demand for the better diagnostic and treatment methods by increasing the prevalence of kidney diseases and in turn, speeding up the market growth.

Other factors propelling the market growth include the changing lifestyle owing to the growing urbanization & industrialization coupled with the growing economic conditions that enable access to the quality life & to the improved healthcare worldwide. Advancements in surgeries, fuel the market growth. In addition, factors such as increasing number of biopsy procedures and rising demand for new techniques for diagnosis of chronic diseases provide major impetus to the market growth.

On the other hand, factors such as prohibitive costs associated with Kidney biopsy and the differential awareness and availability between developing and the developed world are posing challenges to the market growth. Nevertheless, new products and services offered to the developing countries and emerging economies by the well-established market players in the developed countries are filling up this gap. This will resultantly foster the market growth.

Global Kidney Biopsy Market- Competitive Analysis

The global Kidney Biopsy market is a fragmented market with a large number of players. Product development strategy has been curtailed by the excellent efficiency and efficacy of drugs. However, the rise of drug resistance has opened doors for new drug development and is an opportunity for a new market leader. The rise of spurious and counterfeit medicines have reduced the total market revenues and at the same time displaced standard drugs off the market.

The Kidney Biopsy Market Players are Cook Medical (US), Boston Scientific Corporation (US), C R Bard, Inc. (US), Hologic Inc. (US), Devicor Medical Products Inc. (US), Intact Medical Corporation (US), Scion Medical Technologies LLC (US), Precision Biopsy, LLC (US), Integra LifeSciences Corporation (US), Focal Therapeutics, Inc. (US), Creganna (US), CareFusion (US), and Argon Medical Devices, Inc. (US) are some of the prominent players profiled in MRFR Analysis and are at the forefront of competition in the Global Market of Kidney Biopsy.

 

Global Kidney Biopsy Market- Segments

For the convenience of the report and enhanced understanding; the report - Kidney Biopsy Market is segmented in to 4 key dynamics

By Types                     : Comprises Percutaneous and Surgical Biopsy.

By Indications             : Hematuria, Kidney Failure, Proteinuria, and Kidney Transplant.  

By End Users               : Hospitals & Clinics, Tertiary Care Centers, & Urology Centers among others.

By Regions                  :  North America, Europe, APAC and Rest of the World.

Global Kidney Biopsy Market- Regional Analysis

Globally, North America is the largest market for the Kidney Biopsies market insights. Factors such as extensive uptake of technologically advanced medical devices, high expenditures for health care coupled with the governmental support for R&D activities drive the regional growth of the market. Moreover, increasing prevalence of kidney diseases, diabetes, and renal failures are providing impetus to the market growth.

While Europe region stands as the second-largest market for Kidney Biopsies. This growth attributes to the increasing emphasis on the development of advent urology diagnostic devices, rising government support for research & development coupled with the availability of funds. Besides, rising number of specialty services offered by various healthcare providers drive the regional market growth.

However, the developing regions market particularly Asia Pacific will be the fastest growing market for Kidney Biopsies. Factors such as the ever-increasing prevalence of diabetes, and rising number of kidney transplant procedures in urology centers, rapidly developing healthcare technology sector and high healthcare expenditure drive the regional market growth. Furthermore, increasing demand for quality devices in the healthcare is expected to lead the use of advanced equipment, which, in turn, is expected to foster the market growth in APAC region.    

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Epilepsy Diagnosis & Treatment Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 Market overview-

The Global Epilepsy Diagnosis & Treatment Market size is projected to reach USD 10.122 billion by 2032 set to expand at a compound annual growth rate of 14.90% over the forecast period of 2023-2032, proclaims Market Research Future (MRFR) in a detailed research report. Introduction of novel antiepileptic drugs has been a plus for the market growth as it has increased the number of available treatment options. Improved access to therapies has also been instrumental in catalyzing the market growth which has been complemented by substantial expenditure on healthcare on a global scale.

Increasing access to pharmacotherapy, especially in the developing countries of China and India purveyed by government support in the form of medical aids has boosted the growth of the market. The global epilepsy diagnosis & treatment market has witnessed FDA approval of many new drugs in the recent years which has propelled the growth of the market. The overall level of unmet needs is high in the epilepsy market which along with rising prevalence of epilepsy across the globe has aided the growth of the market. However, the high cost of treatment and corrective surgeries and lack of awareness in the developing countries is projected to impede the market growth over the forecast period.

Competitive Landscape

The global epilepsy diagnosis & treatment market players include Pfizer, Inc. (U.S.), UCB Pharma Ltd. (U.K), GlaxoSmithKline plc (U.K), Sanofi S.A. (France), Medtronic (U.S.), Natus Medical Incorporated. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Abbott (U.S.), Novartis International AG (Switzerland), Shire (Republic of Ireland), NeuroWave Systems Inc. (U.S.), Siemens Ltd. (Germany), and others. 

Segmentation

The global epilepsy treatment & diagnosis market has been segmented based on type, diagnosis, treatment, and end user. By type, the market has been segmented into idiopathic, cryptogenic, symptomatic, and others. By diagnosis, the market has been segmented into neurological exam, blood test, imaging, and others. The imaging segment has been further segmented into electroencephalogram, computerized tomography, magnetic resonance imaging, positron emission tomography, and others. By treatment, the market has been segmented into medication, surgery, brain stimulation, and others. The medication segment has been further segmented into acetazolamide, carbamazepine, clobazam, and others. The surgery segment has been further segmented into emporal lobectomy, lesionectomy, and others. The brain stimulation segment has been further segmented into deep brain stimulation, responsive neurostimulation, and others. By end user, the market has been segmented into hospitals & clinics, diagnostic centers and others.

Regional Analysis

The global epilepsy diagnosis & treatment market insights spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas is currently dominating the global market for epilepsy diagnosis & treatment due to a robust healthcare sector, the presence of a vast patient pool, and an increase in a number of head trauma cases. Europe represents the second largest market for epilepsy diagnosis & treatment. A well-developed healthcare sector and government grants for research & development activities drive the market in Europe. Asia Pacific is projected to exhibit substantial growth over the forecast period and grow at the fastest rate. Developing healthcare sector in emerging economies and increasing prevalence of epilepsy in the region fuels the growth of the Asia Pacific market. The Middle East & Africa market accounts for a relatively lower share of the global market. Low expenditure on healthcare, lack of awareness regarding the disease, and stringent government policies, especially in the African region limit the growth of the market. The majority of the market share is held by the Middle East which can be attributed to high healthcare spending and the presence of a well-developed healthcare sector in the Gulf nations.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Bladder Cancer Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Global Bladder Cancer Market - Overview

The global bladder cancer market size is projected to grow USD 8.2 billion by 2032, exhibiting a CAGR 4.60% during the forecast year 2023-2032. growing at a steady pace. This can be attributed to increasing prevalence of bladder cancer. It is reported that the exact cause of the bladder cancer is not clear, however, the medical condition is estimated to be aaocaited with certain factors which are inclusive mutations in the genetic composition of the patients, continuous exposure to harmful radiations, and adoption of unhealthy lifestyle. Such conditions are responsible for increasing the reported cases of bladder cancer across the globe. Moreover, factors such as increasing government support alongwith the growing investment in the research and development procees boosts the market growth. Adfditionally, rising awareness regarding the medical condition among the masses also contributs to the market growth. However, there factors such as  high cost of the treatment in terms of expensive drugs, and related side effects are estimated to restarin the market tgrowth during the projected period.

Global Bladder Cancer Market - Competitive Analysis

The market for bladder cancer is well established market with number of companies operating in this market.

The global bladder cancer market players such as, Oncogenex (US), Astellas (Japan), Eli Lilly and Company (US), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (UK), Accord Healthcare, Inc.(India), Pfizer (US), Novartis AG (Switzerland) Bristol-Myers Squibb company (US) and others. These are some of the major market players at the forefront of competition in the global bladder cancer market.

Bladder Cancer Market is expected to grow in the presence of increasing demands for better rtherapeutics. Currently, the market is witnissing an unavailability of absolute treatment. This can be seen as an for the market players to expand their market. The players, present in the global  bladder cancer market are focusing on the development of new products. Such novel  products are being designed with views of cost effectiveness and minimum side effects. Therefore, many companies in the market are involved in the development of specific types of molecules, and novel therapies have adopted the strategies of the acquisitions, product launches in order to strive in the competitive market. Additionally, competition amongst new entrants is expected to increase the growth for bladder cancer market over the forecasted period.

Global Bladder Cancer Market - Regional Analysis

On the basis of the geography, the global bladder cancer market insights is segmented into the four major regions, namely the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas holds the largest share in the global bladder cancer market.  Presence of huge patient population suffering from bladder cancer is a major reason behind the same. As per the American Cancer Society, approximately 79,030 new cases of bladder cancer were reported  in 2017. Moreover, it was estimated that the disease caused about 16,870 deaths withihn the U.S. Additionally, factors includfing changing lifestyle, rising government support, incrteasing role of cancer care organisations for incraesing the awareness s also impacts a positive  growth in the global bladder cancer market.

Europe accounts for the second largest market share for the bladder cancer, which is followed by Asia Pacific. Asia Pacific is the fastest growing market owing to the huge population base, increasing prevalence of bladder cancer, rapidly developing economies and presence of huge opportunity for the growth of the market. The Middle East & Africa has the least market share due to the unavailability of the required healthcare infrastructure, lack of awareness among people, and affordability issues due to presence of the poor economies in Africa region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Heart Transplant Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 Market Analysis

Acknowledging the numerous innovations transpired in the heart transplant market and the surging traction the market is currently garnering Market Research Future (MRFR) in its recently published study report asserts that the global heart transplant market size is projected to reach USD 24.3 billion by 2032 at a CAGR 10.10% during the forecast year 2023-2032

Heart Transplant or Heart Implant or Cardiac Transplant surgery market is growing rapidly, enhancing the quality of life of people by delivering miraculous results.  Over the past few decades, many innovations have transpired in the field of heart transplant allowing patients an extended lifespan of 13 years approximately with the new heart.

The advancement of effective drugs ascended the success rate of heart transplants to further heights allowing the heart transplant market to witness upsurge. Another predominant factor that contributes to the market growth is the growing prevalence of heart failure and severe coronary artery diseases across the globe.

The advancements in surgical techniques, immunosuppressive modalities, and postoperative care along with the growing prevalence of heart failures and heart-related diseases are boosting the revenues in the market. In recent years, lower availability of donors has prompted significant investments in R&D activities to invent advent technologies and new surgical techniques. These investments, in turn, are defining the immense growth landscape of the heart transplant market insights.

The heart transplant market will gradually subside within a decade with the emergence of artificial pumps and stem cell therapy that will replace the heart transplant. Until then the market will witness its heydays. Simultaneously, insufficient availability of suitable donor’s pool and the complications of a heart transplant such as chances of rejection which basically is immune system’s attacks on transplanted heart, are some of the challenges the market is facing currently. Nevertheless, the emergence of new powerful Immunosuppressive Medications that can control the rejection issues ruling out further chances of acute rejection of the organ will, in turn, support the growth of the heart transplant market. Moreover, the emergence of the Endomyocardial Biopsy coupled with the new high-tech analysis is expected to boost the growth of the Heart Transplant market.

Heart Transplant Market   - Competitive Analysis

The well-established players operating in the highly competitive global market for heart transplant incorporate strategies such as collaboration, acquisition, partnership, technology launch, and expansion, in order to gain the competitive edge in this market.

They also invest substantial funds in R&D and clinical trials to develop effective heart transplant program which is comprehensive, advanced and state-of-the-art. Some hospitals strive to provide tailor-made transplant surgeries based on the ailments, age, and other complications. With advanced diagnostics, and comprehensive rehabilitation schedule these hospitals ensure that patients have access to the best care at every stage of the transplant journey.

Key Players:

The heart transplant market players are.

• SynCardia Systems, LLC,
• Apaxis Medical, Inc.,
• HeartWare,
• Calon Cardio,
• Thoratec Corporation, and
• Optum Inc.

Heart Transplant Market      - Segments

The MRFR analysis is segmented into three key dynamics for enhanced understanding.

By Surgery Types                 : Comprises - Ventricular Assist Devices, and Total Artificial Hearts among others.

By End Users             : Hospitals, Cardiac institutes, Research Centers, and laboratories among others.

By Regions                             :  North America, Europe, APAC, and the Rest-of-the-World.

 

Heart Transplant Market   - Regional Analysis

Globally, North America region accounts for the largest heart transplant market which is estimated to be the major revenue pocket during the review period. The U.S. with its largest number of heart transplants performed (approx. 1700 annually) accounts for one of the major revenue generators in the global market.

Additional factors contributing towards the growth of the market in the region are, increased incidence of heart diseases, technological advancements transpired in the medical sector, increased research & development activities, etc. Besides, rising procurement of transplant diagnostic instruments among medical facilities supports the market growth in the region.

The Europe heart transplant market accounts for the second-largest market, globally owing to the initiatives undertaken by the government and availability of funds. The market is expected to increase steadily throughout the forecast period. Also, huge investments transpired in the healthcare domain are fostering the growth of the market in the region.

The Asia Pacific region is too emerging as one of the promising markets for the heart transplants, growing rapidly. The market is predominantly growing due to the burgeoning medical tourism market in the region. Equipped with the state-of-the-art healthcare infrastructure and flocked with skilled cardiac surgeons, the APAC heart transplant market has improved its reliability for good results.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America